Rôle de l'herpèsvirus humain de type 6 dans le ... - Epublications

nucleoside compound CMV423. Biochem Pharmacol 67, 325-336.
De Bolle, L., Naesens, L. & De Clercq, E. (2005). Update on human herpesvirus 6 biology,
clinical features, and therapy. Clin Microbiol Rev 18, 217-245.
De Clercq, E. & Naesens, L. (2006). In search of effective anti-HHV-6 agents. J Clin Virol 37
Suppl 1, S82-86.
De Clercq, E., Naesens, L., De Bolle, L., Schols, D., Zhang, Y. & Neyts, J. (2001). Antiviral
agents active against human herpesviruses HHV-6, HHV-7 and HHV-8. Rev Med Virol
11, 381-395.
de Pagter, P. J., Schuurman, R., Visscher, H., de Vos, M., Bierings, M., van Loon, A. M.,
Uiterwaal, C. S., van Baarle, D., Sanders, E. A. & Boelens, J. (2008). Human herpes
virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children:
an important risk factor for clinical outcome. Biol Blood Marrow Transplant 14, 831-839.
Denes, E., Magy, L., Pradeau, K., Alain, S., Weinbreck, P. & Ranger-Rogez, S. (2004).
Successful treatment of human herpesvirus 6 encephalomyelitis in immunocompetent
patient. Emerg Infect Dis 10, 729-731.
Desachy, A., Ranger-Rogez, S., Francois, B., Venot, C., Traccard, I., Gastinne, H., Denis, F.
& Vignon, P. (2001). Reactivation of human herpesvirus type 6 in multiple organ failure
syndrome. Clin Infect Dis 32, 197-203.
Descamps, V., Bouscarat, F., Laglenne, S., Aslangul, E., Veber, B., Descamps, D., Saraux, J.
L., Grange, M. J., Grossin, M., Navratil, E., Crickx, B. & Belaich, S. (1997). Human
herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and
reactive haemophagocytic syndrome. Br J Dermatol 137, 605-608.
Descamps, V., Collot, S., Mahe, E., Houhou, N., Crickx, B. & Ranger-Rogez, S. (2003a).
Active human herpesvirus 6 infection in a patient with drug rash with eosinophilia and
systemic symptoms. J Invest Dermatol 121, 215-216.
Descamps, V., Mahe, E., Houhou, N., Abramowitz, L., Rozenberg, F., Ranger-Rogez, S. &
Crickx, B. (2003b). Drug-induced hypersensitivity syndrome associated with Epstein-
Barr virus infection. Br J Dermatol 148, 1032-1034.
Descamps, V., Mardivirin, L. & Ranger-Rogez, S. (2008). Chromosomal integration of human
herpesvirus 6 DNA in anticonvulsant hypersensitivity syndrome: a unique opportunity for
the understanding of their relation. Br J Dermatol 159, 759.
Descamps, V., Valance, A., Edlinger, C., Fillet, A. M., Grossin, M., Lebrun-Vignes, B.,
Belaich, S. & Crickx, B. (2001). Association of human herpesvirus 6 infection with drug
reaction with eosinophilia and systemic symptoms. Arch Dermatol 137, 301-304.
Dewhurst, S., McIntyre, K., Schnabel, K. & Hall, C. B. (1993). Human herpesvirus 6 (HHV-6)
variant B accounts for the majority of symptomatic primary HHV-6 infections in a
population of U.S. infants. J Clin Microbiol 31, 416-418.
Di Luca, D., Katsafanas, G., Schirmer, E. C., Balachandran, N. & Frenkel, N. (1990). The
replication of viral and cellular DNA in human herpesvirus 6-infected cells. Virology 175,
199-210.
Dockrell, D. H. & Paya, C. V. (2001). Human herpesvirus-6 and -7 in transplantation. Rev Med
Virol 11, 23-36.
Dominguez, G., Dambaugh, T. R., Stamey, F. R., Dewhurst, S., Inoue, N. & Pellett, P. E.
(1999). Human herpesvirus 6B genome sequence: coding content and comparison with
human herpesvirus 6A. J Virol 73, 8040-8052.
Downing, R. G., Sewankambo, N., Serwadda, D., Honess, R., Crawford, D., Jarrett, R. &
Griffin, B. E. (1987). Isolation of human lymphotropic herpesviruses from Uganda.
165